AGM Workshops, Symposia, and Webinars
Attendees at the AGM Workshop on High-throughput Screening and Lead Discovery in Bethesda, MD, October 18, 2022.
The AGM program offers training workshops on high-throughput screening and lead discovery, as well as workshops and symposia focused on timely drug discovery and public health challenges. These workshops introduce best practices in early drug discovery and have attracted audiences from academia, government, and pharmaceutical/biotechnology laboratories. The workshops also introduce the scientific community to new technologies and provide participants with opportunities to engage with established drug discovery experts. Many of these workshops are available online for viewing on demand.
The AGM also hosts a quarterly AGM Preclinical Translational Science Webinar Series. This series highlights distinguished translational scientists who share case studies and information about preclinical translational science.
AGM Workshops on High-throughput Screening and Lead Discovery
| Date(s) | Location | Organizer(s) | Related Links |
|---|---|---|---|
| Jan. 25, 2025 | San Diego, CA | SLAS, NCATS | Event information |
| Sept. 24-25, 2024 | Indianapolis, IN | NCATS, Eli Lilly and Company | Event information |
| Feb. 4, 2024 | Boston, MA | SLAS, NCATS | Event information |
| Feb. 25, 2023 | San Diego, CA | SLAS, NCATS | Event information |
| Oct. 18-19, 2022 | Bethesda, MD | NCATS | VideoCast: |
| Feb. 5, 2022 | Boston, MA | SLAS, NCATS | Event information and video recordings |
| Nov. 18-19, 2020 | Virtual | NCATS | Event information and video recordings |
| Jan. 25, 2020 | San Diego, CA | SLAS, NCATS |
AGM Topic-focused Workshops
| Event Name | Summary/goal | Dates | Location | Organizers | Related Links |
|---|---|---|---|---|---|
| In silico Drug Discovery Workshop | This workshop will cover a broad range of critical concepts, including practical approaches and best practices, to successfully develop and integrate accurate, robust, and rigorous AI/ML methods/models into drug discovery pipelines and to facilitate discussions around utilization of such methodologies. This workshop will also cover case studies for AI-driven drug discovery campaigns as well as an overview of new trends and gaps in the field. | Oct. 23-24, 2024 | Virtual | NCATS, BARDA, UCSD, UNC | VideoCast: |
| Assay Guidance Workshop on Sample Management | This workshop aims to provide participants with fundamentals and best practices in sample management, and to introduce participants to emerging trends and technologies in sample management | Oct. 26, 2023 | Virtual | NCATS, SLAS, Vertex Pharmaceuticals | VideoCast: |
| Assay Guidance Workshop on 3D Tissue Models for Antiviral Drug Development | This workshop aimed to provide participants with a roadmap for developing robust and reproducible tissue models to study pandemic threat viruses | June 7-8, 2022 | Virtual | NCATS, NIAID, Bill & Melinda Gates Foundation | VideoCast: |
| Assay Guidance Workshop for Cell-Based Assays and Lead Discovery | This workshop aimed to inform the translational science community on the fundamentals and applications of image-based and 3D cellular assay technologies, and to provide a future perspective on the utility of complex cellular models in drug discovery | Nov. 16-17, 2021 | Virtual | NCATS, Promega, PerkinElmer | VideoCast: |
| Assay Guidance Workshop on DNA-Encoded Libraries (DEL) for Lead Discovery | This workshop aimed to inform the translational science community on the fundamentals and applications of DEL technology, and to bring together those practicing the art to share insights and perspectives in an open forum | Sept. 1-2, 2021 | Virtual | NCATS, Pfizer, Nurix Therapeutics, HitGen Inc., GlaxoSmithKline | VideoCast: |
| The Opioid Crisis and the Future of Addiction and Pain Therapeutics: Opportunities, Tools, and Technologies Symposium | This symposium highlighted challenges and opportunities in the pre-competitive, preclinical stage of development for addiction- and pain-related medications and provided a framework for more focused efforts within the research community | Feb. 7-8, 2019 | NIH Campus, Bethesda, MD | NCATS, NIDA, NINDS | VideoCast: |
AGM Preclinical Translational Science Webinar Series
| Date(s) | Event Name | Speaker | Related Links |
|---|---|---|---|
| Nov. 8, 2024 | Drug Discovery Meets Artificial Intelligence (AI) | Bryan Roth, M.D., Ph.D. | Event Information |
| Sept. 10, 2024 | AI and Machine Learning (ML) in Drug Discovery | Rommie E. Amaro, Ph.D. | Event information and video recordings |
| May 31, 2024 | Cysteine-Directed Molecules as Drug Leads and Probes of ‘Undruggable’ Proteins | Michelle Arkin, Ph.D. | Event information and video recordings |
| Mar. 15, 2024 | AI and ML in Drug Discovery | Derek Lowe, Ph.D. | Event information and video recordings |
| Dec. 1, 2023 | Preclinical Translational Science: The View from Biotech | Christopher P. Austin, M.D. | Event information and video recordings |
| Sept. 22, 2023 | Gene Control Therapeutics | Jay Bradner, M.D. | Event information and video recordings |
| June 2, 2023 | Nav1.7 as a Pain Target and Why Selective Nav1.7 Inhibitors Have Not Yet Shown Efficacy in Clinical Trials | David H. Hackos, Ph.D. | Event information and video recordings |
| Mar. 10, 2023 | Preclinical Cancer Target Validation: How to Avoid Being Wrong (Even if You Fool Reviewer 3) | William G. Kaelin, Jr., M.D. | Event information and video recordings |